Image

An international industrial expert

 

 

 

The Japanese HORIBA Group, which brings together companies from around the world, provides a wide range of instruments and systems for applications ranging from automotive R&D, monitoring processes and the environment, from medical in-vitro diagnostics, from manufacturing semiconductors and metrology to a wide range of measurements for scientific R&D and quality control. Proven quality and consistent performance have made HORIBA a brand that inspires absolute confidence.

 

In Montpellier, the division of the HORIBA Medical group designs, develops and distributes in vitro diagnostics devices in the fields of haematology and clinical chemistry worldwide. These instruments are helping today to prepare for the health of the future.

 

 

HORIBA Medical is ranked 2nd in the European market and 4th in the global haematology market Founded in 1983, the French company ABX has been a subsidiary of HORIBA Group since 1996. The headquarters of HORIBA Medical is located in Montpellier, where the site has a total of 560 employees.

 

HORIBA Medical produces 7,500 instruments per year and more than 6,500 tonnes of reagents. With the new reagent plant opened in Montpellier in 2008, production capacity now exceeds 13,000 tonnes.

 

 

HORIBA Medical

Company headquarters: Montpellier

Production Centres: Japan Brazil France

Local teams: Belgium, Brazil, China, France, India, Italy, Japan, Poland, Portugal, Spain, Thailand, United Kingdom, United States

 

 

Key figures

  • More than 900 employees (including 560 in France)
  • 3 production and research centres - Montpellier, Kyoto, Sao Paulo
  • More than 8% of the turnover earmarked for research

 

 

HORIBA Medical signed a research collaboration contract with IRB in February 2011 in order to improve the diagnostic techniques for haematologic malignancies such as leukaemia or myeloma.

 

The research will be conducted in a joint laboratory at the very heart of this institute, located in the grounds of the Saint Eloi Hospital.

 

This new entity will strengthen the scientific and industrial excellence of the Languedoc-Roussillon Region in the field of in vitro diagnostics.

 

 

www.horiba.com